Connect with us

Technology

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

Published

on

AAT announces additional significant updates

RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ — Advanced Aesthetic Technologies, Inc. (“AAT”) announced today that their partner in China has obtained approval to market their unique dermal filler Algeness® VL agarose facial injection filler, a 2.5% agarose gel dermal filler. AAT’s development and distribution partner is Lanzhou Biotechnique Development Co., Ltd. (“LanDev”), the aesthetic section company of China National Biotec Group Company Limited (belonging to Sinopharm Group, “CNBG”), which acted as the agent for Algeness® VL agarose facial injection filler and obtained the registration license as an imported Class III medical device from the National Medical Products Administration. Algeness® is the first officially approved agarose-based injection filler in China.

Algeness® is the culmination of many years of scientific and clinical research to define a novel biocompatible material to fill wrinkles and volume loss in facial soft tissues. Their team of scientists and physicians worked with Algeness® to create an exceptional 100% natural and biodegradable injectable implant with a unique injection technique.

According to Doug Abel, President and CEO of AAT, “We are excited and look forward to the entry of Algeness® into the large aesthetic market in China through our partner LanDev. We believe that LanDev is the ideal partner to maximize the success of Algeness® in China as they are the sole domestic Chinese manufacturer of botulinum toxin and their product, Hengli, was the first to launch in China and holds significant market share. This approval marks a significant accomplishment by the LanDev, CNBG, AAT, and Ghimas teams and our regulatory advisors and partners.”

“We see the upcoming entry into the market in China with such a strong partner as transformational for the Company, and a demonstration of the clinical performance of this truly unique product,” he adds.

This important achievement follows a series of significant milestones for Advanced Aesthetic Technologies that were reached over the last two years including:

Successfully advancing the clinical trial to be submitted to the US FDA as part of the Pre-Market Authorization (PMA process) through the primary safety and efficacy endpoints with additional, ongoing patient follow up.Advancing the balance of the required information for US FDA submission in 2025.Obtaining the CE Mark under the elevated requirements of the Medical Device Regulations (MDR) initially with therapeutic claims and recently expanding the label to include aesthetic claims under Annex XVI.Acquiring a controlling interest in Ghimas, S.p.A., the original developer and manufacturer of Algeness®.

Plastic Surgeon Dr. Omer Buhsem from Istanbul serves as the Medical Director for Algeness® and has conducted preclinical work with the product portfolio. “I believe that Algeness®, through its unique rheology and structure, brings an important additional tool to our aesthetic armamentarium from both efficacy and safety perspectives. With my patients, I am uniquely able to define the desired shape while working with a product that I have found to be very safe.” Dr. Buhsem has previously published a 700-patient retrospective of his experience with Algeness®.

The unique Algeness® dermal filler continues to receive very positive reviews from aesthetic practitioners globally. According to dermatologist Dr. Tatjana Pavicic of Munich, Germany, “Algeness® is a true revolution in the field of aesthetic medicine. It stands out for its purely natural composition, biocompatibility, and the remarkable, natural-looking results we can achieve for our patients. In our nearly 10 years of experience with Algeness®, my patients report high satisfaction with the immediate lift and long-lasting results, and I appreciate the product’s excellent safety profile and predictability.”

The approval in China combined with the Company’s achievement of critical milestones launches AAT into the next stage. Future commercialization in China combined with the potential for US approval, the significant product performance data developed to support registration, and the unique product profile provide the foundation for Algeness® to have an important place in medical aesthetics.

About Advanced Aesthetic Technologies, Inc.

AAT is a fast-growing, global corporation developing new technologies for aesthetic medicine. Their Algeness® family of injectable implants is the culmination of many years of scientific and clinical research with the goal of providing aesthetic treatment providers with advances in the ability to achieve deep structural support, clean definition, and exceptional clinical outcomes where patients receive their outcome at the time of treatment. Algeness® is a 100% natural and biodegradable filler based on purified agarose with a differentiated clinical and safety performance profile. AAT continuously invests in research and product development to expand the scientific knowledge on Algeness® and agarose while continually pursuing new and innovative technologies to expand our portfolio.

Algeness® is the all-natural, biodegradable, biocompatible agarose-based gel implant, free of all synthetic or cross-linking chemicals. Algeness® dermal fillers add immediate facial volume with excellent persistence without the cross-linking chemicals found in Hyaluronic Acid fillers. It is currently available in many markets in for concentrations of agarose to match specific cosmetic improvements of the lips, fine lines, naso-labial folds and for shaping the cheeks, jawline and other facial areas. In China, only Algeness® VL agarose facial injection filler is now approved for the treatment of nasolabial folds.

As of this release, AAT is in the process of pursuing registration in the U.S. market through the U.S. Food and Drug Administration (FDA).

For more information, Algeness.com

For media inquiries, Media@algeness.com

For more information about Algeness® Dermal Filler: Filler@algeness.com

For inquiries about global distribution: Algeness.com/algeness

Facebook: Facebook.com/Algeness
Instagram: Instagram.com/Algeness/
LinkedIn: https://www.linkedin.com/company/advanced-aesthetic-technologies-inc-algeness/ 

Advanced Aesthetics Technologies, Inc.
150 North Radnor-Chester Road, Suite F-200, Radnor, PA 19087

Logo – https://mma.prnewswire.com/media/1517333/algeness_logo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/advanced-aesthetic-technologies-inc-is-pleased-to-announce-the-approval-of-algeness-vl-agarose-facial-injection-filler-for-marketing-in-china-302362772.html

Continue Reading

Technology

stc group unveils its vision for AI-native networks at Network X 2026

Published

on

By

RIYADH, Saudi Arabia, Oct. 19, 2026 /PRNewswire/ — stc group, Saudi Arabia’s leading digital enabler, has released its AI Native Core Network White Paper during Network X 2026 outlining how it plans to evolve towards an AI-native telecom network by 2030. The paper explains how the group aims to embed AI directly into its network’s design and operations to support emerging digital services and improve reliability.

stc group continues to advance its network capabilities to support AI-driven applications and changing connectivity needs. The group is upgrading its core network, which manages user connections and delivers communications services. By integrating AI deeply into this infrastructure, stc group aims to help the network adapt to changing service requirements and resolve issues with less manual intervention.

The white paper highlights how advances in AI and 5G-Advanced, the next stage of 5G, are increasing network complexity. Services such as AI-enabled calling and immersive communications require faster, more responsive connectivity. AI agents, software systems that carry out tasks on users’ behalf, also need networks to coordinate communications and computing resources around each task.

To address these requirements, the paper sets out stc’s approach spanning AI-native infrastructure, network functions and autonomous operations. It details how the group plans to develop the infrastructure needed to run AI, embed intelligence within network functions and automate more operations. These capabilities would help the network allocate resources more efficiently and recover from faults faster, while allowing engineers to focus on service improvement and oversight.

The release of this whitepaper marks an important milestone in stc group’s network evolution, building a scalable foundation for future AI services, AI agents, intelligent interaction scenarios, and next-generation 5G-A and 6G applications. Building on its existing investments, the group aims to improve network reliability, support the next generation of digital services and accelerate the industry’s transition from Cloud Native to AI Native networks.

About stc group: 

stc group is a digital enabler, offering advanced solutions and driving a role in the digitalization process. The group provides a comprehensive suite of services encompassing digital infrastructure, cloud computing, cybersecurity, Internet of Things (IoT), digital payments, digital media, and digital entertainment. The group comprises 13 subsidiaries across The Kingdom of Saudi Arabia, the Middle East, North Africa, and Europe. 

To know more about stc group: Click here  

View original content:https://www.prnewswire.co.uk/news-releases/stc-group-unveils-its-vision-for-ai-native-networks-at-network-x-2026-302912389.html

Continue Reading

Technology

Shoplazza Collaborates with TikTok to Bring Product Discovery Closer to Purchase

Published

on

By

The collaboration supports TikTok’s new agentic commerce experiences, with a focus on helping merchants turn customer interest into sales.

TORONTO, Oct. 19, 2026 /PRNewswire/ — Shoplazza, an AI-native commerce operating system, recently announced it is working with TikTok to support new agentic commerce shopping experiences. The collaboration reflects a shared focus on shortening the path from product discovery to purchase and helping merchants make more of the demand their content and advertising generate.

TikTok introduced Buy Direct and Shopping Assistant on October 5, naming Shoplazza among its commerce and payment partners. Buy Direct lets consumers buy directly from brands within TikTok, without being redirected to an external storefront. It uses Universal Commerce Protocol (UCP) to connect with merchant systems, while brands remain the Merchant of Record.

Shopping Assistant answers product questions using merchant-supplied information on product pages within TikTok’s in-app browser. Shoppers can get the details they need before proceeding to checkout on the merchant’s website within the same browser.

For merchants, a shorter purchase journey can help protect the value of their customer acquisition spending. Redirects and repeated forms add friction just as a shopper is ready to buy. Losing that purchase means losing potential revenue after already paying to attract the customer.

“As platforms automate more decisions, performance increasingly depends on how well data, creative and checkout work together,” said Chao Xu, Director at Shoplazza. “TikTok’s new shopping experiences make it easier to buy while interest is fresh, helping merchants turn that interest into revenue and use each transaction to inform smarter marketing decisions.”

Shoplazza sees these developments as part of a broader convergence between advertising platforms and commerce infrastructure. From transaction data sharing and Instant Pages to Buy Direct, the opportunity is to help algorithms understand completed purchases more accurately while making it easier for shoppers to follow through.

The collaboration builds on an established relationship. Shoplazza’s merchant admin already supports catalog syncing, TikTok Pixel and Events API setup. In May, it was the sole winner of the TikTok Partner Innovation Award for Innovation in Marketing Technology – Commerce. In July, it joined the first group of TikTok for Business Agentic Hub partners, introducing AI Skills that connect store data and business insights with TikTok’s advertising intelligence.

About Shoplazza

Shoplazza is a global AI-native commerce operating system that enables brands to build, launch, and scale their online businesses. Built on an AI agent-native framework, Shoplazza integrates storefronts, marketing, payments, and operational workflows into a unified system designed to support scalable, long-term growth across global markets. Learn more at https://www.shoplazza.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoplazza-collaborates-with-tiktok-to-bring-product-discovery-closer-to-purchase-302912401.html

SOURCE Shoplazza

Continue Reading

Technology

Lexsoft Systems Partners With Clio to Bring Clio’s Legal AI Platform to Law Firms and Legal Departments Across EMEA

Published

on

By

Lexsoft will deliver Clio products, including Clio Work and Clio Manage, and integrate them into the systems its clients already use

LONDON and MADRID, Oct. 19, 2026 /PRNewswire/ — Lexsoft Systems, a provider of IT and business process solutions, today announced a strategic partnership with Clio, the global leader in legal AI. Through this EMEA-wide partnership, Lexsoft will deliver Clio’s platform to law firms and corporate legal departments, and integrate it with the other business-critical systems those clients run.

This agreement strengthens Lexsoft’s position as an independent legal solutions provider, and reinforces its growing presence in the UK and across Europe. It also supports the continued expansion of its carefully selected product portfolio of best-practice, global market-leading legal systems. 

Clio brings together the context of a firm’s work with trusted legal intelligence. Clio Work can draw on the matters, clients, documents, and other information already in Clio Manage, then ground that work in Clio’s global library of more than 1 billion legal documents to support research, analysis, and drafting. For Lexsoft’s global clients, that means AI designed for legal work that understands both the firm and the law.

“A practice management system is the originating point for most major legal processes — from document management and time recording through to security measures such as ethical walls,” says Carlos García-Egocheaga, CEO of Lexsoft Systems. “Until now, we’ve been reluctant to commit to a single partner, despite a wide choice of technologically robust and functionality-rich practice management systems on the market. But with the Clio platform, we’re offering customers more than practice management. Clio Manage takes practice management to a new level, from user experience to advanced functionality. Clio Work, Clio’s legal AI workspace, helps lawyers research, strategise and draft alongside Clio’s global library of legal documents. By integrating these capabilities into customers’ existing systems, we can deliver AI that works the way they do. We’re excited about the value this partnership enables us to deliver to our customers, large and small.”

The partnership lets Lexsoft build tailored environments around Clio, with deep integrations into the other systems its clients run. It helps firms across EMEA move beyond adoption of AI tools to deeper integration and a more fundamental transformation of how legal work gets done.

“Firms across Europe want AI in their daily work, and it only earns its place when it understands the context behind that work,” says Lisa Del Real, Vice President, Channel Partnerships at Clio. “Lexsoft has built its business on connecting the systems law firms and legal departments depend on. Through this partnership, Lexsoft’s clients can run Clio Manage and Clio Work on one shared foundation, so the context of each matter carries from the business of the firm into the legal work itself. They also get an implementation team that already knows how they work.”

Lexsoft is offering Clio’s products to law firms and corporate legal departments in EMEA immediately.

About Lexsoft Systems

Lexsoft provides IT and business process solutions to the legal sector across Europe, the United States, and Latin America. ISO 27017 and ISO 27001 certified, the company assists law firms and corporate legal departments (CLD) to improve their document management, knowledge management, practice management, and CRM processes, to facilitate business efficiency, improve productivity, and reduce risk. Lexsoft T3 is a proven knowledge management solution, offering one of the most comprehensive workflows for this business function. For more information, visit: www.lexsoft.com.

About Clio

Clio is the global leader in legal AI, empowering legal professionals and law firms of every size to work smarter, faster, and more securely. Purpose-built for the legal industry, Clio’s Intelligent Legal Work Platform streamlines workflows, improves decision-making, and combines powerful technology with industry-leading security. Trusted by hundreds of thousands of legal professionals in more than 130 countries, and approved by over 100 bar associations and law societies worldwide, Clio sets the standard for innovation and client success across the legal profession. Backed by world-class investors and a mission to transform the legal experience for all, Clio is defining the future of legal work through AI. Learn more at www.clio.com.

View original content:https://www.prnewswire.co.uk/news-releases/lexsoft-systems-partners-with-clio-to-bring-clios-legal-ai-platform-to-law-firms-and-legal-departments-across-emea-302910409.html

Continue Reading

Trending